BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26933912)

  • 1. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
    Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
    Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
    Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
    [No Abstract]   [Full Text] [Related]  

  • 4. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
    Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
    Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
    Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer.
    Zacapala-Gómez AE; Navarro-Tito N; Alarcón-Romero LDC; Ortuño-Pineda C; Illades-Aguiar B; Castañeda-Saucedo E; Ortiz-Ortiz J; Garibay-Cerdenares OL; Jiménez-López MA; Mendoza-Catalán MA
    BMC Cancer; 2018 Mar; 18(1):349. PubMed ID: 29587669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
    Chen X; Lan K; Liu Q; Yang X; Wang H
    Tumour Biol; 2017 Mar; 39(3):1010428317695942. PubMed ID: 28351308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma.
    Wang Y; Lin Z; Sun L; Fan S; Huang Z; Zhang D; Yang Z; Li J; Chen W
    Br J Cancer; 2014 Feb; 110(3):695-705. PubMed ID: 24346284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
    Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
    Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
    Miao JW; Liu LJ; Huang J
    Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
    Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
    Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
    Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
    Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
    Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
    BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition.
    Zhou Y; Huang Y; Cao X; Xu J; Zhang L; Wang J; Huang L; Huang S; Yuan L; Jia W; Yu X; Luo R; Zheng M
    PLoS One; 2016; 11(8):e0160414. PubMed ID: 27513465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Ezrin inhibited migration and invasion of cervical cancer cells in vitro.
    Xi M; Tang W
    Int J Immunopathol Pharmacol; 2020; 34():2058738420930899. PubMed ID: 32674647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.